Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammation, the key to much pathology.

Sheila A Doggrell1

  • 1Division of Health Practice, Auckland University of Technology - Akoranga Campus, Northcote, Auckland, New Zealand. s.doggrell@xtra.co.nz

Drug News & Perspectives
|January 5, 2006
PubMed
Summary

New anti-inflammatory drugs and therapeutic targets for respiratory diseases, inflammatory bowel disease, arthritis, atherosclerosis, and cancer were discussed. The World Congress on Inflammation highlighted advancements in treating various inflammatory conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consideration of the use of nalbuphine in idiopathic pulmonary fibrosis-associated cough: to cough or not to cough so much?

Expert opinion on investigational drugs·2026
Same author

Is supplemental vitamin D useful in the clinically isolated syndrome (CIS) typical of multiple sclerosis?

Expert opinion on pharmacotherapy·2026
Same author

Is seltorexant, an orexin-2 receptor antagonist, showing promise in insomnia?

Expert opinion on investigational drugs·2026
Same author

Does varenicline promote abstinence in youths who vape?

Expert opinion on pharmacotherapy·2025
Same author

Reply to: reframing guselkumab's benefit in ulcerative colitis: insights from QUASAR and emerging evidence.

Expert opinion on biological therapy·2025
Same author

With guselkumab, does the dual mechanisms to inhibit IL-23, help in ulcerative colitis?

Expert opinion on biological therapy·2025

Area of Science:

  • Immunology and Medicine
  • Pharmacology and Therapeutics

Background:

  • Inflammation is a key factor in numerous chronic diseases.
  • Effective treatments for inflammatory conditions remain a significant medical challenge.

Framework:

  • The World Congress on Inflammation convened experts to discuss novel therapeutic strategies.
  • Focus areas included respiratory, gastrointestinal, joint, cardiovascular, and oncological inflammatory diseases.

Implementation:

  • Exploration of new drug targets for managing inflammation.
  • Discussion of emerging pharmaceutical agents for various inflammatory conditions.

Implications:

  • Potential for improved patient outcomes in asthma, COPD, inflammatory bowel disease, arthritis, atherosclerosis, and cancer.

Related Experiment Videos

  • Advancements in understanding and treating complex inflammatory disorders.